Progress in the ligands and their complex structures of farnesoid X receptor / 药学学报
Acta Pharmaceutica Sinica
;
(12): 704-715, 2012.
Artigo
em Chinês
| WPRIM
| ID: wpr-276255
ABSTRACT
Farnesoid X receptor (FXR) belongs to the nuclear receptor superfamily. It is highly related to the formation of metabolic syndrome and the glucose homeostasis, and therefore represents an important drug target against metabolic diseases and diabetes. In recent years, great progress has been made in the agonists, antagonists, and crystal structures of FXR. The diverse FXR ligands and their structure-activity relationship are reviewed in this article. The advances in the crystal structures of FXR in complex with different ligands are also introduced.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Farmacologia
/
Pregnenodionas
/
Relação Estrutura-Atividade
/
Azepinas
/
Derivados de Benzeno
/
Estrutura Molecular
/
Química
/
Ácido Quenodesoxicólico
/
Receptores Citoplasmáticos e Nucleares
/
Cristalização
Limite:
Animais
/
Humanos
Idioma:
Chinês
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS